Indirect costs result from diminished productivity and are incorporated in cost-benefit analysis to guide health resource allocation. Valuing the productivity impairment of those not involved in labor market activities is controversial but important for diseases affecting predominantly women if allocation decisions are to be economically efficient and equitable. We compared indirect costs incurred by women with systemic lupus erythematosus (SLE), a prototypical women's disease, calculated under varying assumptions for the value of diminished labor market and non-labor market activity.
|Number of pages||8|
|Journal||The Journal of Rheumatology|
|Publication status||Published - Nov 2000|
- Cost of Illness
- Lupus Erythematosus, Systemic
- Middle Aged
- Women's Health